about
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR.Telomeres and telomerase in normal and malignant B-cells.Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival.Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis.HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data.Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up.Highly sensitive MYD88L265P mutation detection by droplet digital PCR in Waldenström Macroglobulinemia.Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease NetworkMinimal Residual Disease in Indolent Lymphomas: A Critical AssessmentNew Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid MalignanciesMinimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network
P50
Q34973576-979BF8C1-A0B2-4FF4-8B7A-FF0192CA1A88Q35759705-CA8743FF-F597-4C9A-9605-431A25ACF4E5Q37705182-72B43DF3-E346-493C-9F8E-13F52D03D3C9Q43837244-D85F86D4-F5B3-4B67-8DB7-658595E8C14DQ47367539-026B2374-E11E-4135-A89D-042F6C64C75BQ47423302-016BF2B3-B5B9-4FDE-8A97-007DD09C6AF8Q48335780-39D92ED1-9180-4B1C-8B35-517ECD4FC2FBQ52641888-0166DCC5-079C-41DC-AD48-F2D5A5E4239EQ53163477-6887F134-017E-480F-AECC-E59CFBB1E667Q56970793-73EA747B-684D-41A2-84ED-E8EFEDD112DCQ58606498-27436BC4-B432-4F81-8305-F1E4611EE69BQ58723303-F6913096-F6D1-4204-ACD1-AF446FD7F780Q92038315-BF72248E-6E54-46EE-A633-19D44DD4BD6F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
E Genuardi
@ast
E Genuardi
@es
E Genuardi
@nl
Elisa Genuardi
@en
Elisa Genuardi
@pl
type
label
E Genuardi
@ast
E Genuardi
@es
E Genuardi
@nl
Elisa Genuardi
@en
Elisa Genuardi
@pl
altLabel
E Genuardi
@en
prefLabel
E Genuardi
@ast
E Genuardi
@es
E Genuardi
@nl
Elisa Genuardi
@en
Elisa Genuardi
@pl
P106
P21
P31
P496
0000-0002-9624-0337